NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









J-One Capital

J-One Capital

Shanghaij-onecapital.com

Overview

J-One Capital (formerly known as Sinopharm Capital) is a Shanghai-based private equity investment firm focused on the healthcare and life sciences sectors in China.

Year Founded

2012

Portfolio Companies

6

Investments

CompanyDateStageLead
Shanghai OE Biotech Co., Ltd.Nov 2021Series A ExtensionLead
Geneus Technologies (Chengdu) Co., Ltd.Sep 2021Series BCo-investor
Shanghai Zymetas Medtech Co., Ltd.May 2021Series DCo-investor
Zhejiang Pushkang Biotechnology Co., Ltd.Apr 2020Series BCo-investor
SonmolAug 2019Series CCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




ProductsSecondary Data & TradingCaplight MarketPrice™Company DatabaseInvestor DatabaseSourcingAPI & MCP

Use CasesInvestorsEmployees

ResourcesResearch & BlogAboutCareers

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.